GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the Deferred Prosecution Agreement (DPA) entered into effective December 7, 2010 with the United States Attorney’s Office for the District of New Jersey (USAO) has expired. The Company satisfied its obligations under the DPA and has received a Notice of Dismissal of the Complaint filed against it in this matter in the United States District Court for the District of New Jersey. Neither the DPA nor the Complaint alleged that the Company’s conduct adversely affected patient health or patient care.
Like the other orthopaedic companies who completed their DPAs, Exactech is under a Corporate Integrity Agreement (CIA) administered by the Office of Inspector General of the U.S. Department of Health and Human Services. Exactech’s CIA extends until December 7, 2015.
Exactech Chairman and CEO Bill Petty said, “We are pleased to reach closure of this process and to have the systems in place to ensure effective, efficient compliance. We will continue to practice the highest standards of ethics, which have been and will continue to be hallmarks of our corporate culture.”
Exactech Announces Expiration of Deferred Prosecution Agreement
(Visited 2 times, 1 visits today)
I have been in the medical device indusrty for 30 years. I accepted a job with Exactech, they paid my relocation from Zimmer of Indiana. I worked for them for 2 years, left the company due to their corrupt exchange for favors or influence in the medical field. During my 2 year at Exactech Ive seen wide spread Ecactech managment poisoning their mfg workers minds and the poison atmosphere within the offices.